Zai Lab Limited (ADR)
General ticker "ZLAB" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $3.4B (TTM average)
Zai Lab Limited (ADR) follows the US Stock Market performance with the rate: 2.3%.
Estimated limits based on current volatility of 1.1%: low 19.63$, high 20.07$
Factors to consider:
- Total employees count: 1869 (-14.1%) as of 2024
- Company does not operate outside US (retrieved using AI)
- Top business risk factors: Geopolitical risks, Market acceptance, Operational and conduct risks, Third-party risks, Cybersecurity threats
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [17.92$, 38.11$]
- 2025-12-31 to 2026-12-31 estimated range: [15.12$, 32.83$]
Short-term ZLAB quotes
Long-term ZLAB plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $215.04MM | $276.72MM | $398.99MM |
| Operating Expenses | $619.40MM | $643.29MM | $681.11MM |
| Operating Income | $-404.36MM | $-366.57MM | $-282.12MM |
| Non-Operating Income | $-38.71MM | $31.95MM | $25.01MM |
| Interest Expense | $0.00MM | $0.00MM | $2.25MM |
| R&D Expense | $286.41MM | $265.87MM | $234.50MM |
| Income(Loss) | $-443.06MM | $-334.62MM | $-257.10MM |
| Other Income(Loss) | $-0.22MM | $0.00MM | $0.00MM |
| Profit(Loss)* | $-443.29MM | $-334.62MM | $-257.10MM |
| Stockholders Equity | $1,045.60MM | $796.12MM | $840.90MM |
| Inventory | $31.62MM | $44.83MM | $39.88MM |
| Assets | $1,220.14MM | $1,036.30MM | $1,185.75MM |
| Operating Cash Flow | $-367.64MM | $-198.18MM | $-214.87MM |
| Capital expenditure | $24.98MM | $8.49MM | $61.52MM |
| Investing Cash Flow | $420.02MM | $-10.78MM | $-375.19MM |
| Financing Cash Flow | $-1.73MM | $-6.43MM | $349.89MM |
| Earnings Per Share** | $-46.27 | $-34.63 | $-2.60 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.